Darling Ingredients posts mixed Q3 print, shares edge lower

Darling Ingredients reported Q3 2026 adjusted EPS of $1.67, below the $1.83 analyst estimate, while revenue of $1.79 billion matched consensus and rose 14.5% year over year. Combined adjusted EBITDA more than doubled to $514.3 million, and net debt fell approximately $420 million; the company also repurchased $75.9 million of stock in the quarter. Darling reaffirmed FY2026 adjusted EBITDA guidance of $2.2 billion–$2.3 billion and expects year-end net debt at or below $3.0 billion; shares fell 0.9% after the results.

Analysis

Read-through: The key tension is earnings quality versus cash generation. Strong combined EBITDA and Diamond Green Diesel (DGD) distributions support deleveraging, but they do not erase the EPS miss; investors should verify the bridge from EBITDA to attributable earnings and free cash flow rather than extrapolate the headline EBITDA growth. DGD’s $1.30 adjusted EBITDA per gallon is an important near-term sensitivity, not a stable earnings run-rate: renewable-fuel credit values, feedstock costs and policy changes can compress it quickly.

Catalyst and hurdle: Reaffirmed FY26 guidance implies roughly $540–640 million of combined EBITDA in Q4, with about $590 million at the midpoint—above Q3’s $514.3 million. That makes delivery, not the reaffirmation itself, the next test. Over the next 1–3 months, watch for management commentary on DGD unit economics and the Q4 bridge; over 6–18 months, policy-credit economics and feedstock availability matter more than current-quarter distributions. Debt reduction lowers financial risk, but using cash distributions for buybacks competes with further balance-sheet repair if DGD cash flows weaken.

Contrarian view: The modest share reaction may underweight the Q4 execution hurdle; equally, treating one quarter’s DGD economics as durable could overstate the structural upside. No clear directional edge without the EPS-to-cash-flow reconciliation and more evidence on DGD margins.

Key Decisions for Investors

• Stay neutral rather than chase the EBITDA headline. Reassess after the next operating update or results, focusing on whether the Q4 guidance range remains achievable and on the EPS-to-cash-flow bridge.
• Treat roughly $540 million of Q4 combined EBITDA—the implied low end of reaffirmed guidance—as a key falsification threshold. A guidance cut or evidence that DGD unit economics are deteriorating would weaken the deleveraging and buyback thesis.
• For an existing DAR position, avoid adding until management provides a credible Q4 bridge; consider reducing exposure if the stock rallies without improved earnings conversion. Verify DGD credit and feedstock economics, and the source of the EPS shortfall, before taking a directional position.